EUVIMEDOpdag EUVIMED
Crossref

FOS‐Mediated PLCB1 Induces Radioresistance and Weakens the Antitumor Effects of CD8 + T Cells in Triple‐Negative Breast Cancer

Yuxian Shu, Jun Lan, Huijing Luo, Huiying Fu, Xuhuang Xiao, Liping Yang

Molecular Carcinogenesis · 2025

DOI: 10.1002/mc.23834 ↗

At a glance

Journal article in Molecular Carcinogenesis, 2025. Written by Yuxian Shu and 5 co-authors. Institution: Department of Breast Comprehensive Radiotherapy, Jiangxi Cancer Hospital, Nanchang, Jiangxi, People's Republic of China. Major MEDLINE topics: Triple Negative Breast Neoplasms, Radiation Tolerance, Phospholipase C beta, CD8-Positive T-Lymphocytes. Cited 6 times so far (Crossref); 32 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Radioresistance and immune evasion are interactive and crucial events leading to treatment failure and progression of human malignancies. This research studies the role of phospholipase C beta 1 (PLCB1) in these events in triple‐negative breast cancer (TNBC) and the regulatory mechanism. PLCB1 was bioinformatically predicted as a dysregulated gene potentially linked to radioresistance in TNBC. Parental TNBC cell lines were exposed to fractionated radiation for 6 weeks. PLCB1 expression was decreased in the first 2 weeks but gradually increased from Week 3. PLCB1 knockdown increased the radiosensitivity of the cells, as manifested by a decreased half‐inhibitory dose of irradiation, reduced cell proliferation, apoptosis resistance, mobility, and tumorigenesis in mice. The FOS transcription factor promoted PLCB1 transcription and activated the PI3K/AKT signaling. Knockdown of FOS similarly reduced radioresistance and T cells‐mediated immune evasion. However, the radiosensitivity of TNBC cells and the antitumor effects of CD8 + T cells could be affected by a PI3K/AKT activator or by the PLCB1 upregulation. The PLCB1 or FOS knockdown also suppressed radioresistance and tumorigenesis of the TNBC cells in mice. In conclusion, FOS‐mediated PLCB1 induces radioresistance and weakens the antitumor effects of CD8 + T cells in TNBC by activating the PI3K/AKT signaling pathway.

Subjects

MeSH terms (MEDLINE)

Triple Negative Breast NeoplasmsRadiation TolerancePhospholipase C betaCD8-Positive T-LymphocytesCell ProliferationProto-Oncogene Proteins c-fosAnimalsHumansFemaleMiceCell Line, TumorApoptosisSignal TransductionGene Expression Regulation, NeoplasticPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akt

Author keywords

CD8+ T cellsFOSPLCB1radioresistancetriple‐negative breast cancer

Substances

Phospholipase C betaProto-Oncogene Proteins c-fosPLCB1 protein, humanFOS protein, humanPhosphatidylinositol 3-KinasesProto-Oncogene Proteins c-akt

Authors and institutions

  • Department of Breast Comprehensive Radiotherapy, Jiangxi Cancer Hospital, Nanchang, Jiangxi, People's Republic of China.
  • First Department of General Surgery, Jiangxi Gao'an People's Hospital, Gao'an, Jiangxi, People's Republic of China.
  • Department of Oncology, Taihe County People's Hospital, Ji'an, Jiangxi, People's Republic of China.
  • Department of Oncology, No.908 Hospital, Joint Logistics Support Force, Nanchang, Jiangxi, People's Republic of China.
  • Department of Oncology, Taihe County Traditional Chinese Medicine Hospital, Ji'an, Jiangxi, People's Republic of China.
  • Department of Breast Surgery, Jiangxi Cancer Hospital, Nanchang, Jiangxi, People's Republic of China.

Cite

APA

Shu, Y., Lan, J., Luo, H., Fu, H., Xiao, X., & Yang, L. (2025). FOS‐Mediated PLCB1 Induces Radioresistance and Weakens the Antitumor Effects of CD8 + T Cells in Triple‐Negative Breast Cancer. Molecular Carcinogenesis. https://doi.org/10.1002/mc.23834

Vancouver

Shu Y, Lan J, Luo H, Fu H, Xiao X, Yang L. FOS‐Mediated PLCB1 Induces Radioresistance and Weakens the Antitumor Effects of CD8 + T Cells in Triple‐Negative Breast Cancer. Molecular Carcinogenesis. 2025. doi:10.1002/mc.23834

BibTeX
@article{Shu2025,
  author = {Shu, Yuxian and Lan, Jun and Luo, Huijing and Fu, Huiying and Xiao, Xuhuang and Yang, Liping},
  title = {FOS‐Mediated PLCB1 Induces Radioresistance and Weakens the Antitumor Effects of CD8 + T Cells in Triple‐Negative Breast Cancer},
  journal = {Molecular Carcinogenesis},
  year = {2025},
  doi = {10.1002/mc.23834}
}
Start for free →